WALTHAM, Mass., Sept. 18, 2017 /PRNewswire/ -- Alere Inc. (NYSE:
ALR), a global leader in rapid diagnostics, has declared a cash
dividend of $3.00 per share on its
Series B Convertible Perpetual Preferred Stock (NYSE: ALR-B). The
dividend is payable on October 16,
2017 to holders of record of Series B stock at the close of
business on October 2, 2017.
Such payment will cover the amount of all dividends accrued from
July 1, 2017 through September 30, 2017.
Abbott Laboratories has made an offer to purchase for cash all
outstanding shares of Series B Convertible Perpetual Preferred
Stock at $402.00 per share, plus
accrued but unpaid dividends to, but not including, the settlement
date of the offer. For more details, see the Tender Offer
Statement on Schedule TO (together with the exhibits and amendments
thereto) filed by Abbott with the Securities and Exchange
Commission on July 17, 2017. As set
forth in the Solicitation/Recommendation Statement filed by Alere
with the Securities and Exchange Commission on Schedule 14D-9 on
July 21, 2017, Alere makes no
recommendation, expresses no opinion and remains neutral regarding
whether holders of shares of Series B Convertible Perpetual
Preferred Stock should participate in this offer.
Cautionary Statement Regarding Forward-Looking
Statements
This communication contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Readers can identify these statements by forward-looking
words such as "may," "could," "should," "would," "intend," "will,"
"expect," "anticipate," "believe," "estimate," "continue" or
similar words. A number of important factors could cause actual
results of Alere and its subsidiaries to differ materially from
those indicated by such forward-looking statements. These factors
include, but are not limited to, the risk factors detailed in Part
I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for
the fiscal year ended December 31,
2016 (as filed with the Securities and Exchange Commission
on June 5, 2017) and other risk
factors identified herein or from time to time in our periodic
filings with the SEC. Readers should carefully review these risk
factors, and should not place undue reliance on our forward-looking
statements. These forward-looking statements are based on
information, plans and estimates at the date of this communication.
We undertake no obligation to update any forward-looking statements
to reflect changes in underlying assumptions or factors, new
information, future events or other changes.
About Alere
Alere believes that when diagnosing and
monitoring health conditions, Knowing now matters™. Alere
delivers on this vision by providing reliable and actionable
information through rapid diagnostic tests, enhancing clinical and
economic health outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid
diagnostics for infectious disease, cardiometabolic disease and
toxicology. For more information on Alere, please visit
www.alere.com.
View original
content:http://www.prnewswire.com/news-releases/alere-inc-declares-cash-dividend-on-its-series-b-convertible-perpetual-preferred-stock-300521638.html
SOURCE Alere Inc.